Metabolic Memory in Diabetes – Mechanistic Insights and the Impact of Cardiovascular Medication

1 Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A. The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications. Vol. 9, Nutrients. 2017. TestaR BonfigliAR PrattichizzoF La SalaL De NigrisV CerielloA The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications 9 Nutrients 2017 10.3390/nu9050437545216728452927 Search in Google Scholar

2 Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656–62. GuzikTJ MussaS GastaldiD SadowskiJ RatnatungaC PillaiR Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase Circulation. 2002 105 14 1656 62 10.1161/01.CIR.0000012748.58444.0811940543 Search in Google Scholar

3 F Giacco MB. Oxidative stress and diabetic complications. Giacco F1, Brownlee M. Circ Res. 2010; F GiaccoMB Oxidative stress and diabetic complications Giacco F1, Brownlee M. Circ Res 2010 10.1161/CIRCRESAHA.110.223545299692221030723 Search in Google Scholar

4 Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. In: Diabetes. 2005. p. 1615–25. BrownleeM The pathobiology of diabetic complications: A unifying mechanism In: Diabetes 2005 1615 25 10.2337/diabetes.54.6.161515919781 Search in Google Scholar

5 Brouwers O, Niessen PM, Haenen G, Miyata T, Brownlee M, Stehouwer CD, et al. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia. 2010;53(5):989–1000. BrouwersO NiessenPM HaenenG MiyataT BrownleeM StehouwerCD Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress Diabetologia. 2010 53 5 989 1000 10.1007/s00125-010-1677-0285052420186387 Search in Google Scholar

6 M. N, A. S, B. S, T. G, T. H, C. G, et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. American Journal of Clinical Nutrition. 2007. NM. SA. SB. GT. HT. GC. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus American Journal of Clinical Nutrition 2007 Search in Google Scholar

7 Yamagishi SI. Advanced Glycation End-Products. In: Brenner's Encyclopedia of Genetics: Second Edition. 2013. p. 36–8. YamagishiSI Advanced Glycation End-Products In: Brenner's Encyclopedia of Genetics: Second Edition 2013 36 8 10.1016/B978-0-12-374984-0.00476-9 Search in Google Scholar

8 Tanaka N, Yonekura H, Yamagishi SI, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-Estradiol through sp-1 in human vascular endothelial cells. J Biol Chem. 2000;275(33): 25781–90. TanakaN YonekuraH YamagishiSI FujimoriH YamamotoY YamamotoH The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-Estradiol through sp-1 in human vascular endothelial cells J Biol Chem. 2000 275 33 25781 90 10.1074/jbc.M00123520010829018 Search in Google Scholar

9 Wang H, Liu J, Wu L. Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells. Biochem Pharmacol. 2009; 77(11):1709–16. WangH LiuJ WuL Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells Biochem Pharmacol. 2009 77 11 1709 16 10.1016/j.bcp.2009.02.02419428325 Search in Google Scholar

10 Shamoon H, Cleary P, Barnie A, Genuth S, Maffin C, Tamborlane W, et al. Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22(1):99–111. ShamoonH ClearyP BarnieA GenuthS MaffinC TamborlaneW Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort Diabetes Care. 1999 22 1 99 111 10.2337/diacare.22.1.99274593810333910 Search in Google Scholar

11 Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994;43(9):1122–9. XiaP InoguchiT KernTS EngermanRL OatesPJ KingGL Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia Diabetes. 1994 43 9 1122 9 10.2337/diab.43.9.11228070612 Search in Google Scholar

12 Steinberg SF. Structural basis of protein kinase C isoform function. Vol. 88, Physiological Reviews. 2008. p. 1341–78. SteinbergSF Structural basis of protein kinase C isoform function 88 Physiological Reviews 2008 1341 78 10.1152/physrev.00034.2007289968818923184 Search in Google Scholar

13 Ganz MB, Seftel A. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiol - Endocrinol Metab. 2000;278(1 41–1). GanzMB SeftelA Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E Am J Physiol - Endocrinol Metab 2000 278 1 41 1 10.1152/ajpendo.2000.278.1.E14610644549 Search in Google Scholar

14 Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andrean D, et al. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes. 1994;43(3):478–90. PuglieseG PricciF PuglieseF MeneP LentiL AndreanD Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells Diabetes. 1994 43 3 478 90 10.2337/diab.43.3.4788314022 Search in Google Scholar

15 Takagi C, Bursell SE, Lin YW, Takagi H, Duh E, Jiang Z, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Investig Ophthalmol Vis Sci. 1996;37(12):2504–18. TakagiC BursellSE LinYW TakagiH DuhE JiangZ Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1 Investig Ophthalmol Vis Sci. 1996 37 12 2504 18 Search in Google Scholar

16 Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol - Endocrinol Metab. 1993;265(5 28–5). ShibaT InoguchiT SportsmanJR HeathWF BursellS KingGL Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation Am J Physiol - Endocrinol Metab 1993 265 5 28 5 10.1152/ajpendo.1993.265.5.E7838238505 Search in Google Scholar

17 Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest. 1997;100(1):115–26. KoyaD JirousekMR LinYW IshiiH KubokiK KingGL Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats J Clin Invest. 1997 100 1 115 26 10.1172/JCI1195035081719202063 Search in Google Scholar

18 KOYA D, HANEDA M, NAKAGAWA H, ISSHIKI K, SATO H, MAEDA S, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 2000;14(3):439–47. KOYAD HANEDAM NAKAGAWAH ISSHIKIK SATOH MAEDAS Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J. 2000 14 3 439 47 10.1096/fasebj.14.3.43910698958 Search in Google Scholar

19 Pugliese G, Tilton RG, Williamson JR. Glucose–induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 1991;7(1):35–59. PuglieseG TiltonRG WilliamsonJR Glucose–induced metabolic imbalances in the pathogenesis of diabetic vascular disease Diabetes Metab Rev. 1991 7 1 35 59 10.1002/dmr.56100701061935535 Search in Google Scholar

20 Vikramadithyan RK, Hu Y, Noh HL, Liang CP, Hallam K, Tall AR, et al. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest. 2005;115(9):2434–43. VikramadithyanRK HuY NohHL LiangCP HallamK TallAR Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice J Clin Invest. 2005 115 9 2434 43 10.1172/JCI24819119037116127462 Search in Google Scholar

21 Sayeski PP, Kudlow JE. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription. J Biol Chem. 1996;271(25):15237–43. SayeskiPP KudlowJE Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription J Biol Chem. 1996 271 25 15237 43 10.1074/jbc.271.25.152378663078 Search in Google Scholar

22 Schleicher ED, Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney International, Supplement. 2000. SchleicherED WeigertC Role of the hexosamine biosynthetic pathway in diabetic nephropathy Kidney International, Supplement 2000 10.1046/j.1523-1755.2000.07703.x10997685 Search in Google Scholar

23 James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, et al. Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation. Diabetes. 2002;51(4):1146–56. JamesLR TangD IngramA LyH ThaiK CaiL Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation Diabetes. 2002 51 4 1146 56 10.2337/diabetes.51.4.1146 Search in Google Scholar

24 Wang Z, Zhao H, Guan W, Kang X, Tai X, Shen Y. Metabolic memory in mitochondrial oxidative damage triggers diabetic retinopathy. BMC Ophthalmol. 2018;18(1). WangZ ZhaoH GuanW KangX TaiX ShenY Metabolic memory in mitochondrial oxidative damage triggers diabetic retinopathy BMC Ophthalmol. 2018 18 1 10.1186/s12886-018-0921-0 Search in Google Scholar

25 Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Vol. 414, Nature. 2001. p. 813–20. BrownleeM Biochemistry and molecular cell biology of diabetic complications 414 Nature 2001 813 20 10.1038/414813a Search in Google Scholar

26 Bernardi S, Michelli A, Zuolo G, Candido R, Fabris B. Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease. Journal of Diabetes Research. 2016. BernardiS MichelliA ZuoloG CandidoR FabrisB Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease Journal of Diabetes Research 2016 10.1155/2016/8917578 Search in Google Scholar

27 Wu Y, Tang L, Chen B. Oxidative stress: Implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Vol. 2014, Oxidative Medicine and Cellular Longevity. 2014. WuY TangL ChenB Oxidative stress: Implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives 2014 Oxidative Medicine and Cellular Longevity 2014 10.1155/2014/752387 Search in Google Scholar

28 Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, et al. Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia. 2006;49(12):3094–9. YoshidaT YamagishiS NakamuraK MatsuiT ImaizumiT TakeuchiM Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation Diabetologia. 2006 49 12 3094 9 10.1007/s00125-006-0437-7 Search in Google Scholar

29 Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet. 2008;372(9647):1385–93. SjølieAK KleinR PortaM OrchardT FullerJ ParvingHH Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial Lancet. 2008 372 9647 1385 93 10.1016/S0140-6736(08)61411-7 Search in Google Scholar

30 Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet. 2008;372(9647):1394–402. ChaturvediN PortaM KleinR OrchardT FullerJ ParvingHH Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials Lancet. 2008 372 9647 1394 402 10.1016/S0140-6736(08)61412-9 Search in Google Scholar

31 Miller AG, Tan G, Binger KJ, Pickering RJ, Thomas MC, Nagaraj RH, et al. Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes. 2010;59(12):3208–15. MillerAG TanG BingerKJ PickeringRJ ThomasMC NagarajRH Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function Diabetes. 2010 59 12 3208 15 10.2337/db10-0552299278420852029 Search in Google Scholar

32 Silva KC, Rosales MAB, Biswas SK, De Faria JBL, De Faria JML. Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes. 2009; SilvaKC RosalesMAB BiswasSK De FariaJBL De FariaJML Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes Diabetes 2009 10.2337/db09-0166268268319289456 Search in Google Scholar

33 Zhang X, Lassila M, Cooper ME, Cao Z. Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors. Hypertension. 2004;43(2 I):276–81. ZhangX LassilaM CooperME CaoZ Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors Hypertension. 2004 43 2 I 276 81 10.1161/01.HYP.0000113628.94574.0f14718351 Search in Google Scholar

34 Simão S, Santos DF, Silva GA. Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells. Angiogenesis. 2017;20(1):175–81. SimãoS SantosDF SilvaGA Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells Angiogenesis. 2017 20 1 175 81 10.1007/s10456-016-9526-527695972 Search in Google Scholar

35 Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation. 2005;111(19):2518–24. CerielloA AssaloniR Da RosR MaierA PiconiL QuagliaroL Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients Circulation. 2005 111 19 2518 24 10.1161/01.CIR.0000165070.46111.9F15867169 Search in Google Scholar

36 Carrillo-Ibarra S, Miranda-Díaz AG, Sifuentes-Franco S, Cardona-Muñoz EG, Rodríguez-Carrizalez AD, Villegas-Rivera G, et al. Effect of statins on oxidative DNA damage in diabetic polyneuropathy. J Circ Biomarkers. 2018;7. Carrillo-IbarraS Miranda-DíazAG Sifuentes-FrancoS Cardona-MuñozEG Rodríguez-CarrizalezAD Villegas-RiveraG Effect of statins on oxidative DNA damage in diabetic polyneuropathy J Circ Biomarkers. 2018 7 10.1177/1849454418804099617096130302131 Search in Google Scholar

37 Berezin A. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives. Vol. 10, Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2016. p. S176–83. BerezinA Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives 10 Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2016 S176 83 10.1016/j.dsx.2016.03.01627025794 Search in Google Scholar

38 Zhao S, Li J, Wang N, Zheng B, Li T, Gu Q, et al. Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway. Mol Med Rep. 2015;12(4):6112–8. ZhaoS LiJ WangN ZhengB LiT GuQ Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway Mol Med Rep. 2015 12 4 6112 8 10.3892/mmr.2015.416426238659 Search in Google Scholar